Pertuzumab, trastuzumab, and docetaxel for HER2-positive metastatic breast cancer (CLEOPATRA): end-of-study results from a double-blind, randomised, placebo-controlled, phase 3 study
Swain, Sandra M, Miles, David, Kim, Sung-Bae, Im, Young-Hyuck, Im, Seock-Ah, Semiglazov, Vladimir, Ciruelos, Eva, Schneeweiss, Andreas, Loi, Sherene, Monturus, EstefanÃa, Clark, Emma, Knott, Adam, ReJournal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30863-0
Date:
March, 2020
File:
PDF, 396 KB
2020
File converter
More search results
More benefits 
